ADVERTISEMENT
2 /3 FREE ARTICLES LEFT THIS MONTH Remaining
Chemistry matters. Join us to get the news you need.

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

Pharmaceuticals

Ebola Drugs Readied For African Tests

by Michael McCoy
September 29, 2014 | APPEARED IN VOLUME 92, ISSUE 39

Investigational Ebola treatments from biotech firms including Mapp Biopharmaceutical, Sarepta Therapeutics, and Tekmira Pharmaceuticals will be tested in West Africa for the first time as part of an international fast-track Ebola trials initiative. Backed by a $5.2 million grant from the Wellcome Trust, the program will include funds for the manufacture of drugs as well as the establishment of several clinical testing sites.

X

Article:

This article has been sent to the following recipient:

Leave A Comment

*Required to comment